Antidepressant treatment and cortical 5-hydroxytryptamine₂A receptors

Payne, Geoffrey Wallace (1997) Antidepressant treatment and cortical 5-hydroxytryptamine₂A receptors. Masters thesis, Memorial University of Newfoundland.

[English] PDF - Accepted Version Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission. Download (1MB)

Abstract

The aim of this research was to functionally assess changes in cortical 5-hydroxytryptamine₂A (5-HT ₂A) receptors following exposure to drugs used to treat depression or to electroconvulsive shock. The literature suggests a possible role for 5-HT₂A receptors in the onset and treatment of depression but, to date, no extensive functional assessment of cortical S-HT₂A receptors has been undertaken to determine how important a role this plays. -- N-methyl-D-aspartate (NMDA) depolarizes cortical neurons and this depolarization is enhanced by 5-HT acting at 5-HT₂A receptors. Using this facilitation as a measure of 5-HT₂A receptor activity the functionality of 5-HT₂A receptors on cortical neurons was assessed following acute and chronic exposure to imipramine, fluoxetine or mianserin. These results were compared with those following a course of electroconvulsive treatment (ECT). -- The results showed that following chronic (14 day), but not acute (2 day) exposure to imipramine and fluoxetine, the 5-HT concentration response relationship was shifted to the right and exhibited a lower maximum response compared to controls. In contrast, mianserin, a 5-HT₂A receptor antagonist which also exhibits antidepressant efficacy, produced a similar shift and reduced maximum following acute exposure. ECT did not alter the 5-HT concentration-response relationship. Neither drug exposure nor ECT significantly altered NMDA responses. -- Based on these results it is concluded that cortical 5-HT₂A receptor down-regulation may be an important event in mediating the therapeutic response achieved following chronically administered antidepressants. 5-HT₂A receptor down-regulation may shift the balance from excitatory 5-HT₂A receptors in favor of inhibitory 5-HT₂A receptors, co-localized on postsynaptic cortical neurons. Thus, a rise in synaptic 5-HT levels following chronic antidepressant treatment increases the activity of postsynaptic 5-HT₁A receptors and results in an increase in inhibitory 5-HT neurotransmission. A rise in inhibitory 5-HT neurotransmission could counteract the increase in excitatory 5-HT activity thought to occur in depressed individuals. This represents a return in net 5-HT activity to a homeostatic level, alleviating symptoms associated with depression.

Actions (login required)

View Item